Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Cardiovascular outcomes with sodium-glucose cotransporter-2 inhibitors vs other glucose-lowering drugs in 13 countries across three continents: analysis of CVD-REAL data.
Khunti K, Kosiborod M, Kim DJ, Kohsaka S, Lam CSP, Goh SY, Chiang CE, Shaw JE, Cavender MA, Tangri N, Franch-Nadal J, Holl RW, Jørgensen ME, Norhammar A, Eriksson JG, Zaccardi F, Karasik A, Magliano DJ, Thuresson M, Chen H, Wittbrodt E, Bodegård J, Surmont F, Fenici P; CVD-REAL Investigators and Study Group. Khunti K, et al. Among authors: surmont f. Cardiovasc Diabetol. 2021 Jul 31;20(1):159. doi: 10.1186/s12933-021-01345-z. Cardiovasc Diabetol. 2021. PMID: 34332558 Free PMC article.
Considerations when planning and conducting large global observational studies: Experience from the DISCOVER study of patients with type 2 diabetes.
Aarskog P, Cid-Ruzafa J, Chen H, Fenici P, Gutierrez LR, Hammar N, Medina J, Pascual E, Saraiva GL, Surmont F, Sweet S, Ji L, Khunti K, Cooper A. Aarskog P, et al. Among authors: surmont f. Prim Care Diabetes. 2023 Oct;17(5):411-419. doi: 10.1016/j.pcd.2023.07.002. Epub 2023 Aug 5. Prim Care Diabetes. 2023. PMID: 37544790 Free article. Review.
Treatment patterns and glycated haemoglobin levels over 36 months in individuals with type 2 diabetes initiating second-line glucose-lowering therapy: The global DISCOVER study.
Charbonnel BH, Chen H, Cid-Ruzafa J, Cooper A, Fenici P, Gomes MB, Saraiva GL, Medina J, Nicolucci A, Shestakova MV, Shimomura I, Surmont F, Tang F, Vora J, Watada H, Khunti K; DISCOVER Investigators. Charbonnel BH, et al. Among authors: surmont f. Diabetes Obes Metab. 2023 Jan;25(1):46-55. doi: 10.1111/dom.14842. Epub 2022 Sep 16. Diabetes Obes Metab. 2023. PMID: 36111434 Free PMC article.
Socioeconomic Factors Associated With Glycemic Measurement and Poor HbA1c Control in People With Type 2 Diabetes: The Global DISCOVER Study.
Gomes MB, Tang F, Chen H, Cid-Ruzafa J, Fenici P, Khunti K, Rathmann W, Shestakova MV, Surmont F, Watada H, Medina J, Shimomura I, Saraiva GL, Cooper A, Nicolucci A. Gomes MB, et al. Among authors: surmont f. Front Endocrinol (Lausanne). 2022 Apr 22;13:831676. doi: 10.3389/fendo.2022.831676. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35527995 Free PMC article.
Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North America.
Quint JK, Arnetorp S, Kocks JWH, Kupczyk M, Nuevo J, Plaza V, Cabrera C, Raherison-Semjen C, Walker B, Penz E, Gilbert I, Lugogo NL, van der Valk RJP; SABINA North American and European Study contributors. Quint JK, et al. J Allergy Clin Immunol Pract. 2022 Sep;10(9):2297-2309.e10. doi: 10.1016/j.jaip.2022.02.047. Epub 2022 Mar 29. J Allergy Clin Immunol Pract. 2022. PMID: 35364341 Free article.
Design and rationale of DISCOVER global registry in type 2 diabetes: Real-world insights of treatment patterns and its relationship with cardiovascular, renal, and metabolic multimorbidities.
Khunti K, Heerspink HJL, Lam CSP, Nicolucci A, Ramirez L, Surmont F, Fenici P, Kosiborod M. Khunti K, et al. Among authors: surmont f. J Diabetes Complications. 2021 Dec;35(12):108077. doi: 10.1016/j.jdiacomp.2021.108077. Epub 2021 Oct 13. J Diabetes Complications. 2021. PMID: 34686406 Free article.
Incidence rates and predictors of microvascular and macrovascular complications in patients with type 2 diabetes: Results from the longitudinal global discover study.
Arnold SV, Khunti K, Tang F, Chen H, Cid-Ruzafa J, Cooper A, Fenici P, Gomes MB, Hammar N, Ji L, Saraiva GL, Medina J, Nicolucci A, Ramirez L, Rathmann W, Shestakova MV, Shimomura I, Surmont F, Vora J, Watada H, Kosiborod M. Arnold SV, et al. Among authors: surmont f. Am Heart J. 2022 Jan;243:232-239. doi: 10.1016/j.ahj.2021.10.181. Epub 2021 Oct 16. Am Heart J. 2022. PMID: 34666013
Early versus late intensification of glucose-lowering therapy in patients with type 2 diabetes: Results from the DISCOVER study.
Ji L, Bonnet F, Chen H, Cooper A, Hammar N, Leigh P, Luporini Saraiva G, Ramirez L, Medina J, Nicolucci A, Rathmann W, Shestakova MV, Surmont F, Tang F, Watada H; DISCOVER Investigators. Ji L, et al. Among authors: surmont f. Diabetes Res Clin Pract. 2021 Aug;178:108947. doi: 10.1016/j.diabres.2021.108947. Epub 2021 Jul 10. Diabetes Res Clin Pract. 2021. PMID: 34252505
Type 2 diabetes and heart failure: insights from the global DISCOVER study.
Arnold SV, Khunti K, Bonnet F, Charbonnel B, Chen H, Cid-Ruzafa J, Cooper A, Fenici P, Gomes MB, Hammar N, Ji L, Luporini-Saraiva G, Medina J, Nicolucci A, Ramirez L, Shestakova MV, Shimomura I, Surmont F, Tang F, Vora J, Watada H, Kosiborod M; DISCOVER investigators. Arnold SV, et al. Among authors: surmont f. ESC Heart Fail. 2021 Apr;8(2):1711-1716. doi: 10.1002/ehf2.13235. Epub 2021 Feb 11. ESC Heart Fail. 2021. PMID: 33570253 Free PMC article.
33 results